Management of hemochromatosis

Annals of Internal Medicine

Volumn 129, Issue 11, 1998, Pages 932-939

  Barton, James C ^a,b   McDonnell, Sharon M ^c   Adams, Paul C ^d   Brissot, Pierre ^e   Powell, Lawrie W ^f   Edwards, Corwin Q ^g   Cook, James D ^h   Kowdley, Kris V ⁱ   Cocchiarella, Linda ^j   Dooley, James S ^j   Fellitti, Vincent ^j   Brandhagen, David ^j   Herbert, Victor ^j   Krikker, Margit A ^j  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b S Iron Overload Disorders (JCB)   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIINFLAMMATORY AGENT; FERRITIN; MINERAL; VITAMIN;

ARTHROPATHY; ARTICLE; CARDIOMYOPATHY; DIABETES MELLITUS; DIET THERAPY; HEMOCHROMATOSIS; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; IRON ABSORPTION; IRON INTAKE; IRON OVERLOAD; LIVER CANCER; LIVER CIRRHOSIS; PHLEBOTOMY; PRIORITY JOURNAL; SHELLFISH; VIBRIO VULNIFICUS; BLOOD; DIET; FEMALE; GENETICS; HETEROZYGOTE; HOMOZYGOTE; MALE; REVIEW;

DIET; FEMALE; FERRITINS; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; PHLEBOTOMY;

EID: 0032401727     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-11_part_2-199812011-00003     Document Type: Article

References (86)

1. Powell LW, Jazwinska E, Halliday JW. Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron Metabolism in Health and Disease. Philadelphia: WB Saunders; 1994:227-70.
2. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guidelines development task force of the College of America Pathologists. Hereditary hemochromatosis. Clin Chim Acta. 1996;245:139-200.
3. Barton JC, Bertoli LF, Janich MR, Arthur MW, Alford TJ. Normal transferrin saturation in hemochromatosis. Hosp Pract (Off Ed). 1991;26(Suppl 3):46-8.
4. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. Journal of Pathology and Bacteriology. 1962;84:53-64.
5. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepathology. 1986;6:24-9.
6. Brissot P, Bourel M, Herry D, Verger JP, Messner M, Beaumont C, et al. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology. 1981;80:557-65.
7. Searle J, Kerr JF, Halliday JW, Powell LW. Iron storage disease. In: Mc-Sween RN, Anthony PP, Scheuer PJ, Burt AD, Portmann BC, eds. Pathology of the Liver. 3d ed. New York: Churchill Livingstone; 1993:219-41.
8. Barton JC, Harmon L, Rivers C, Acton RT. Hemochromatosis: association of severity of iron overload with genetic markers. Blood Cells Mol Dis. 1996; 22:195-204.
9. Bonkovsky HL, Slaker DP, Bills EB, Wolf DC. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology. 1990;99:1079-91.
10. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet. 1997;349:321-3.
11. Mohler DN, Wheby MS. Hemochromatosis heterozygotes may have significant iron overload when they also have hereditary spherocytosis. Am J Med Sci. 1986;292:320-4.
12. Edwards CQ, Griffen LM, Kushner JP. Coincidental hemochromatosis and viral hepatitis. Am J Med Sci. 1991;301:50-4.
13. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology. 1992;102: 2108-13.
14. Barton JC, Barton NH, Alford TJ. Diagnosis of hemochromatosis probands in a community hospital. Am J Med. 1997;103:498-503.
15. Davis WD, Arrowsmith WR. The effect of repeated phlebotomies in hemochromatosis: report of three cases. J Lab Clin Med. 1952;39:526-32.
16. Wohler F. The treatment of haemochromatosis with desferrioxamine. Acta Haematol. 1963;30:65-87.
17. Kellner H, Zoller WG. Repeated isovolemic large-volume erythrocytapheresis in the treatment of idiopathic hemochromatosis. Z Gastroenterol. 1992;30: 779-83.
18. Haddy TB, Castro OL, Rana SR. Hereditary hemochromatosis in children, adolescents, and young adults. Am J Pediatr Hematol Oncol. 1988; 10:23-34.
19. Kaltwasser JP, Schalk KP, Werner E. Juvenile hemochromatosis. In: Weintraub LR, Edwards CQ, Krikker M, eds. Hemochromatosis. Proceedings of the First International Conference. Ann NY Acad Sci. 1988;526:339-41.
20. Kaikov Y, Wadsworth LD, Hassall E, Dimmick JE, Rogers PC. Primary hemochromatosis in children: report of three newly diagnosed cases and review of the pediatric literature. Pediatrics. 1992;90(1 pt 1):37-42.
21. Pippard MJ, Rajagopalan B, Callender ST, Weatherall DJ. Iron loading, chronic anaemia, and erythroid hyperplasia as determinants of the clinical features of β-thalassaemia intermedia. In: Weatherall DJ, Fiorelli G, Gorini S, eds. Advances in Red Blood Cell Biology. New York: Raven Pr; 1982:103-13.
22. McLaren CE, Gordeuk VR, Looker AC, Hasselblad V, Edwards CQ, Griffen LM, et al. Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood. 1995;86:2021-7.
23. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med. 1996;335:1799-805.
24. Barton JC, Shih WW, Sawada-Hirai R, Acton RT, Harmon L, Rivers C, et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis. 1997;23:135-45.
25. Lundvall O. Phlebotomy treatment of porphyria cutanea tarda. Acta Derm Venereol Suppl (Stockh). 1982;100:107-18.
26. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet. 1997;349:321-3.
27. Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology. 1998;27:181-4.
28. Bilgrami S, Bartolomeo A, Synnott V, Rickles FR. Management of hemosiderosis complicated by coexistent anemia with recombinant human erythropoietin and phlebotomy. Acta Haematol. 1993;89:141-3.
29. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med. 1985;313:1256-62.
30. Edwards CQ, Dadone MM, Skolnick MH, Kushner JP. Hereditary hemochromatosis. Clin Haematol. 1982;11:411-35.
31. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med. 1997;127:105-10.
32. Sham RL, Ou CY, Cappuccio J, Braggins C, Dunnigan K, Phatak PD. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Blood Cell Mol Dis. 1997;23:314-20.
33. Skikne B, Baynes RD. Iron absorption. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron Metabolism in Health and Disease. Philadelphia: WB Saunders; 1994:151-88.
34. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988;318:1355-62.
35. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol. 1994;89:986-8.
36. Piperno A, Sampietro M, D'Alba R, Roffi L, Fargion S, Parma S, et al. Iron stores response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver. 1996;16:248-54.
37. Stremmel W, Niederau C, Berger M, Kley HK, Krüskemper HL, Strohmeyer G. Abnormalities in estrogen, androgen, and insulin metabolism in idiopathic hemochromatosis. In: Weintraub LR, Edwards CQ, Krikker M, eds. Hemochromatosis. Proceedings of the First International Conference. Ann N Y Acad Sci 1988;526:209-23.
38. Cutler DJ, Isner JM, Bracey AW, Hufnagel CA, Conrad PW, Roberts WC, et al. Hemochromatosis heart disease: an unemphasized cause of potentially reversible restrictive cardiomyopathy. Am J Med. 1980;69:923-8.
39. Candell-Riera J, Lu L, Seres L, Gonzalez JB, Batlle J, Permanyer-Miralda G, et al. Cardiac hemochromatosis: beneficial effects of iron removal therapy. An echocardiographic study. Am J Cardiol. 1983;52:824-9
40. Rivers J, Garrahy P, Robinson W, Murphy A. Reversible cardiac dysfunction in hemochromatosis. Am Heart J. 1987;113:216-7.
41. Powell LW. Hemochromatosis: precirrhotic therapy restores normal life expectancy. Hepatology. 1986;6:1423-5.
42. Adams PC, Speechley M, Kertesz AE. Long-term survival in hereditary hemochromatosis. Gastroenterology. 1991;101:368-72.
43. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110:1107-19.
44. Knauer CM, Gamble CN, Monroe LS. The reversal of hemochromatic cirrhosis by phlebotomies. Report of a case. Gastroenterology. 1965;49:667-71.
45. Weintraub LR, Conrad ME, Crosby WH. The treatment of hemochromatosis by phlebotomy. Med Clin North Am. 1966;50:1579-90.
46. Powell LW, Kerr JF. Reversal of "cirrhosis" in idiopathic haemochromatosis following long-term intensive venesection therapy. Australas Ann Med. 1970; 19:54-7.
47. Blumberg RS, Chopra S, Ibrahim R, Crawford J, Farraye FA, Zeldis JB, et al. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology. 1988;95:1399-402.
48. Schumacher HR, Straka PC, Krikker MA, Dudley AT. The arthropathy of hemochromatosis. Recent studies. In: Weintraub LR, Edwards CQ, Krikker M, eds. Hemochromatosis. Proceedings of the First International Conference. Ann N Y Acad Sci. 1988;526:224-33.
49. Kelly TM, Edwards CQ, Meikle AW, Kushner JP. Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med. 1984;101:629-32.
50. Lufkin EG, Baldus WP, Bergstralh EJ, Kao PC. Influence of phlebotomy treatment on abnormal hypothalamic-pituitary function in genetic hemochromatosis. Mayo Clin Proc. 1987;62:473-9.
51. Siminoski K, D'Costa M, Walfish PG. Hypogonadotrophic hypogonadism in idiopathic hemochromatosis: evidence for combined hypothalamic and pituitary involvement. J Endocrinol Invest. 1990;13:849-53.
52. Farina G, Pedrotti C, Cerani P, Rovati A, Strada E, Bergamaschi G, et al. Successful pregnancy following gonadotropin therapy in a young female with juvenile idiopathic hemochromatosis and secondary hypogonadotrophic hypogonadism. Haematologica. 1995;80:335-7.
53. Edwards CQ, Kelly TM, Ellwein G, Kushner JP. Thyroid disease in hemochromatosis. Increased incidence in homozygous men. Arch Intern Med. 1983;143:1890-3.
54. Edwards CQ, Griffen LM, Kaplan J, Kushner JP. Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes. J Intern Med. 1989;226:373-9.
55. Bradbear RA, Bain C, Siskind V, Schofield FD, Webb S, Axelsen EM, et al. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J Natl Cancer Inst. 1985;75:81-4.
56. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991;325:675-80.
57. Deugnier YM, Guyader D, Crantock L, Lopez JM, Turlin B, Yaouanq J, et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology. 1993;104:228-34.
58. Fargion S, Fracanzani AL, Piperno A, Braga M, D'Alba R, Ronchi G, et al. Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology. 1994;20:1426-31.
59. Nonami T, Harada A, Kurokawa T, Nakao A, Takagi H. Hepatic resection for hepatocellular carcinoma. Am J Surg. 1997;173:288-91.
60. Liu CL, Fan ST. Nonresectional therapies for hepatocellular carcinoma. Am J Surg. 1997;173:358-65.
61. Powell LW. Does transplantation of the liver cure genetic hemochromatosis? J Hepatol. 1992;16:259-61.
62. Farrell FJ, Nguyen M, Woodley S, Imperial JC, Garcia-Kennedy R, Man K, et al. Outcome of liver transplantation in patients with hemochromatosis. Hepatology. 1994;20:404-10.
63. Poulos JE, Bacon BR. Liver transplantation for hereditary hemochromatosis. Dig Dis. 1996;14:316-22.
64. Kowdley KV, Hassanein T, Kaur S, Farrell FJ, Van Thiel DH, Keeffe EB, et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transpl Surg. 1995;1:237-41.
65. Askari AD, Muir WA, Rosner IA, Moskowitz RM, McLaren GD, Braun WE. Arthritis of hemochromatosis. Clinical spectrum, relation to histocompatibility antigens, and effectiveness of early phlebotomy. Am J Med. 1983;75: 957-65.
66. Edwards CQ, Cartwright GE, Skolnick MH, Amos DB. Homozygosity for hemochromatosis: clinical manifestations. Ann Intern Med. 1980;93:519-25.
67. Bothwell TH, Charlton RW, Cook JD, Finch CA. Iron absorption In: Iron Metabolism in Man. Oxford: Blackwell Scientific; 1979:256-83.
68. Conrad ME, Barton JC. Factors affecting iron balance. Am J Hematol. 1981; 10:199-205.
69. de Alarcon PA, Donovan ME, Forbes GB, Landaw S, Stockman JA 3d. Iron absorption in the thalassemia syndromes and its inhibition by tea. N Engl J Med. 1979;300:5-8.
70. Celada A, Rudolf H, Donath A. Effect of experimental chronic alcohol ingestion and folic acid deficiency on iron absorption. Blood. 1979;54:906-15.
71. Conrad ME, Barton JC. Anemia and iron kinetics in alcoholism. Semin Hematol. 1980;17:149-63.
72. LeSage GD, Baldus WP, Fairbanks VF, Baggenstoss AH, McCall JT, Moore SB, et al. Hemochromatosis: genetic or alcohol-induced? Gastroenterology. 1983;84:1471-7.
73. Nienhuis AW. Vitamin C and iron [Editorial]. N Engl J Med. 1981;304:170-1.
74. Brissot P, Deugnier Y, Le Treut A, Regnouard F, Simon M, Bourel M. Ascorbic acid status in idiopathic hemochromatosis. Digestion. 1978;17:469-87.
75. McLaren O, Bett JH, Nye JA, Halliday JW. Congestive cardiomyopathy and haemochromatosis - rapid progression possibly accelerated by excessive ingestion of ascorbic acid. Aust N Z J Med. 1982;12:187-8.
76. Brissot P, Le Treut A, Dien G, Cottencin M, Simon M, Bourel M. Hypovitaminemia A in idiopathic hemochromatosis and hepatic cirrhosis. Role of retinol-binding protein and zinc. Digestion. 1978;17:469-78.
77. Barton JC, Patton MA, Edwards CQ, Griffen LM, Kushner JP, Meeks RG, et al. Blood lead concentrations in hereditary hemochromatosis. J Lab Clin Med. 1994;124:193-8.
78. Butt EM, Nusbaum RE, Gilmour TC, DiDio SL. Trace metal patterns in disease states. Hemochromatosis, Bantu siderosis and iron storage in Laennec's cirrhosis and alcoholism. In: Seven MJ, Johnson LA, eds. Metal-Binding in Medicine: Proceedings of a Symposium. Philadelphia: JB Lippincott; 1960: 43-9.
79. Olatunbosun D, Corbett WE, Ludwig J, Valberg LS. Alteration of cobalt absorption in portal cirrhosis and idiopathic hemochromatosis. J Lab Clin Med. 1977;75:754-62.
80. Altstatt LB, Pollack S, Feldman MH, Reba RC, Crosby WH. Liver manganese in hemochromatosis. Proc Soc Exp Biol Med. 1967;124:353-5.
81. Spencer H, Sontag SJ, Derler J, Osis D. Intestinal absorption of iron in patients with hemochromatosis. Ann N Y Acad Sci. 1988;526:336-8.
82. Adams PC, Bradley C, Frei JV. Hepatic zinc in hemochromatosis. Clin Invest Med. 1991;14:16-20.
83. Barton JC, Bertoli LF. Zinc gluconate lozenges for treating the common cold [Letter]. Ann Intern Med. 1997;126:738-9.
84. Muench KH. Hemochromatosis and infection: alcohol and iron, oysters and sepsis. Am J Med. 1989;87:40N-3N.
85. Bullen JJ, Spalding PB, Ward CG, Gutteridge JM. Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch Intern Med. 1991;151:1606-9.
86. Hlady WG, Klontz KC. The epidemiology of Vibrio infections in Florida, 1981-1993. J Infect Dis. 1996;173:1176-83.